» Articles » PMID: 28880125

Consensus Statement of the International Summit on Intellectual Disability and Dementia Related to Post-diagnostic Support

Overview
Publisher Routledge
Specialty Geriatrics
Date 2017 Sep 8
PMID 28880125
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Post diagnostic support (PDS) has varied definitions within mainstream dementia services and different health and social care organizations, encompassing a range of supports that are offered to adults once diagnosed with dementia until death.

Method: An international summit on intellectual disability and dementia held in Glasgow, Scotland in 2016 identified how PDS applies to adults with an intellectual disability and dementia. The Summit proposed a model that encompassed seven focal areas: post-diagnostic counseling; psychological and medical surveillance; periodic reviews and adjustments to the dementia care plan; early identification of behaviour and psychological symptoms; reviews of care practices and supports for advanced dementia and end of life; supports to carers/ support staff; and evaluation of quality of life. It also explored current practices in providing PDS in intellectual disability services.

Results: The Summit concluded that although there is limited research evidence for pharmacological or non-pharmacological interventions for people with intellectual disability and dementia, viable resources and guidelines describe practical approaches drawn from clinical practice. Post diagnostic support is essential, and the model components in place for the general population, and proposed here for use within the intellectual disability field, need to be individualized and adapted to the person's needs as dementia progresses.

Conclusions: Recommendations for future research include examining the prevalence and nature of behavioral and psychological symptoms (BPSD) in adults with an intellectual disability who develop dementia, the effectiveness of different non-pharmacological interventions, the interaction between pharmacological and non-pharmacological interventions, and the utility of different models of support.

Citing Articles

Preliminary translation of 'Reducing Disability in Alzheimer's Disease' among individuals with intellectual disabilities and caregiver dyads.

Ptomey L, Barton K, Swinford E, Bodde A, George A, Gorczyca A J Appl Res Intellect Disabil. 2024; 37(3):e13239.

PMID: 38621995 PMC: 11067498. DOI: 10.1111/jar.13239.


Enhancing post-diagnostic care in Australian memory clinics: Health professionals' insights into current practices, barriers and facilitators, and desirable support.

Pavkovic S, Goldberg L, Farrow M, Alty J, Abela M, Naismith S Dementia (London). 2023; 23(1):109-131.

PMID: 38116661 PMC: 10797845. DOI: 10.1177/14713012231213419.


Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.

Dierssen M, Herault Y, Helguera P, Martinez de Lagran M, Vazquez A, Christian B Mol Syndromol. 2021; 12(4):202-218.

PMID: 34421499 PMC: 8339505. DOI: 10.1159/000514437.


Down syndrome.

Antonarakis S, Skotko B, Rafii M, Strydom A, Pape S, Bianchi D Nat Rev Dis Primers. 2020; 6(1):9.

PMID: 32029743 PMC: 8428796. DOI: 10.1038/s41572-019-0143-7.


Highlights from the International Summit on Intellectual Disability and Dementia Implications for Brazil.

Santos F, Watchman K, Janicki M Dement Neuropsychol. 2018; 12(4):329-336.

PMID: 30546842 PMC: 6289481. DOI: 10.1590/1980-57642018dn12-040001.